IGC Pharma
IGC
#10700
Rank
S$32.9 M
Marketcap
S$0.32
Share price
1.02%
Change (1 day)
-41.63%
Change (1 year)
IGC Pharma, Inc. (formerly India Globalization Capital, Inc.) is a clinical-stage pharmaceutical company focused on developing advanced treatments for diseases, with a primary focus on Alzheimer's disease and other neurological conditions.

IGC Pharma (IGC) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : S$3.92 Million

According to IGC Pharma's latest financial reports the company's total liabilities are S$3.92 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

IGC Pharma - Total liabilities on balance sheet (from 2006 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-03-31S$3.24 M-6.66%
2024-03-31S$3.47 M15.38%
2023-03-31S$3.01 M-24.33%
2022-03-31S$3.98 M-3.32%
2021-03-31S$4.12 M18.46%
2020-03-31S$3.47 M187.67%
2019-03-31S$1.2 M-66.92%
2018-03-31S$3.65 M-33.46%
2017-03-31S$5.49 M-17.03%
2016-03-31S$6.62 M-13.61%
2015-03-31S$7.66 M69.72%
2014-03-31S$4.51 M-14.94%
2013-03-31S$5.3 M-55.26%
2012-03-31S$11.86 M-13.35%
2011-03-31S$13.69 M6.36%
2010-03-31S$12.87 M-39.33%
2009-03-31S$21.22 M-42.47%
2008-03-31S$36.9 M36.93%
2007-03-31S$26.94 M5.08%
2006-03-31S$25.64 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Sterling Infrastructure
STRL
S$2.31 B 58,767.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Trinity Industries
TRN
S$9.07 B 231,176.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Granite Construction
GVA
S$5.08 B 129,584.73%๐Ÿ‡บ๐Ÿ‡ธ USA